CytoMed Therapeutics Ltd (GDTC:NASDAQ)

$1.08 0.04 (3.85%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 84

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed CytoMed Therapeutics Ltd (GDTC:NASDAQ) News Sources

Cyprium Therapeutics inks agreement to sell rare paediatric disease priority review voucher for $205 million

Pharmabiz

external link

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion

The Economic Times

external link
GDTC stock
GDTC stock price
GDTC stock price today
GDTC stock prediction
GDTC earnings date
GDTC news
GDTC price
GDTC share
GDTC share price
GDTC shares
GDTC ceo
GDTC premarket
$GDTC
GDTC ticker
GDTC after hours
GDTC stock
GDTC stock price
GDTC stock price today
GDTC stock prediction
GDTC earnings date
GDTC news
GDTC price
GDTC share
GDTC share price
GDTC shares
GDTC ceo
GDTC premarket
$GDTC
GDTC ticker
GDTC after hours

CytoMed Therapeutics Ltd (GDTC:NASDAQ) FAQs

toggle

What is the current price of CytoMed Therapeutics Ltd (GDTC:NASDAQ)?

The current price of CytoMed Therapeutics Ltd (GDTC:NASDAQ) is $1.08.


toggle

CytoMed Therapeutics Ltd (GDTC:NASDAQ) absolute price change since previous trading day?

The absolute price change of CytoMed Therapeutics Ltd (GDTC:NASDAQ) since the previous trading day is $0.04.


toggle

CytoMed Therapeutics Ltd (GDTC:NASDAQ) percentage price change since previous trading day?

The percentage price change of CytoMed Therapeutics Ltd (GDTC:NASDAQ) since the previous trading day is 3.85%.


toggle

What is This Week's average sentiment score for CytoMed Therapeutics Ltd (GDTC:NASDAQ)?

This Week's average sentiment score for CytoMed Therapeutics Ltd (GDTC:NASDAQ) is 84 out of 100.


toggle

What is This Week's average sentiment for CytoMed Therapeutics Ltd (GDTC:NASDAQ)?

This Week's sentiment for CytoMed Therapeutics Ltd (GDTC:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.